289 related articles for article (PubMed ID: 24147898)
41. Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment.
Bagre AP; Jain K; Jain NK
Int J Pharm; 2013 Nov; 456(1):31-40. PubMed ID: 23994363
[TBL] [Abstract][Full Text] [Related]
42. Systemic heparin delivery by the pulmonary route using chitosan and glycol chitosan nanoparticles.
Trapani A; Di Gioia S; Ditaranto N; Cioffi N; Goycoolea FM; Carbone A; Garcia-Fuentes M; Conese M; Alonso MJ
Int J Pharm; 2013 Apr; 447(1-2):115-23. PubMed ID: 23454518
[TBL] [Abstract][Full Text] [Related]
43. Characteristics and antioxidant activity of Elsholtzia splendens extract-loaded nanoparticles.
Lee JS; Kim GH; Lee HG
J Agric Food Chem; 2010 Mar; 58(6):3316-21. PubMed ID: 20187637
[TBL] [Abstract][Full Text] [Related]
44. Facile preparation of well-defined near-monodisperse chitosan/sodium alginate polyelectrolyte complex nanoparticles (CS/SAL NPs) via ionotropic gelification: a suitable technique for drug delivery systems.
Liu P; Zhao X
Biotechnol J; 2013 Jul; 8(7):847-54. PubMed ID: 23625874
[TBL] [Abstract][Full Text] [Related]
45. Formulation, optimization and characterization of cationic polymeric nanoparticles of mast cell stabilizing agent using the Box-Behnken experimental design.
Gajra B; Patel RR; Dalwadi C
Drug Dev Ind Pharm; 2016; 42(5):747-57. PubMed ID: 26559522
[TBL] [Abstract][Full Text] [Related]
46. Cetirizine dihydrochloride loaded microparticles design using ionotropic cross-linked chitosan nanoparticles by spray-drying method.
Li FQ; Ji RR; Chen X; You BM; Pan YH; Su JC
Arch Pharm Res; 2010 Dec; 33(12):1967-73. PubMed ID: 21191762
[TBL] [Abstract][Full Text] [Related]
47. Preparation and characterization of spray dried inhalable powders containing chitosan nanoparticles for pulmonary delivery of isoniazid.
Pourshahab PS; Gilani K; Moazeni E; Eslahi H; Fazeli MR; Jamalifar H
J Microencapsul; 2011; 28(7):605-13. PubMed ID: 21793647
[TBL] [Abstract][Full Text] [Related]
48. Preparation of N,O-carboxymethyl chitosan nanoparticles as an insulin carrier.
Lin CC; Lin CW
Drug Deliv; 2009 Nov; 16(8):458-64. PubMed ID: 19839790
[TBL] [Abstract][Full Text] [Related]
49. Chitosan nanoparticles: Polyphosphates cross-linking and protein delivery properties.
Abdelgawad AM; Hudson SM
Int J Biol Macromol; 2019 Sep; 136():133-142. PubMed ID: 31199974
[TBL] [Abstract][Full Text] [Related]
50. Innovative Vancomycin-Loaded Hydrogel-Based Systems - New Opportunities for the Antibiotic Therapy.
Florczyk A; Krajcer A; Wójcik K; Lewandowska-Łańcucka J
Int J Nanomedicine; 2024; 19():3991-4005. PubMed ID: 38720939
[TBL] [Abstract][Full Text] [Related]
51. Chitosan/montmorillonite composite nanospheres for sustained antibiotic delivery at post-implantation bone infection treatment.
Kimna C; Deger S; Tamburaci S; Tihminlioglu F
Biomed Mater; 2019 May; 14(4):044101. PubMed ID: 30991372
[TBL] [Abstract][Full Text] [Related]
52. Chitosan coated vancomycin hydrochloride liposomes: Characterizations and evaluation.
Yang Z; Liu J; Gao J; Chen S; Huang G
Int J Pharm; 2015 Nov; 495(1):508-515. PubMed ID: 26325316
[TBL] [Abstract][Full Text] [Related]
53. Injectable Chitosan-Based Thermosensitive Hydrogel/Nanoparticle-Loaded System for Local Delivery of Vancomycin in the Treatment of Osteomyelitis.
Tao J; Zhang Y; Shen A; Yang Y; Diao L; Wang L; Cai D; Hu Y
Int J Nanomedicine; 2020; 15():5855-5871. PubMed ID: 32848394
[TBL] [Abstract][Full Text] [Related]
54. Preparation and evaluation of anti-neuroexcitation peptide (ANEP) loaded N-trimethyl chitosan chloride nanoparticles for brain-targeting.
Wang S; Jiang T; Ma M; Hu Y; Zhang J
Int J Pharm; 2010 Feb; 386(1-2):249-55. PubMed ID: 19900520
[TBL] [Abstract][Full Text] [Related]
55. Preparation, Characterization, and Optimization of Folic Acid-Chitosan-Methotrexate Core-Shell Nanoparticles by Box-Behnken Design for Tumor-Targeted Drug Delivery.
Naghibi Beidokhti HR; Ghaffarzadegan R; Mirzakhanlouei S; Ghazizadeh L; Dorkoosh FA
AAPS PharmSciTech; 2017 Jan; 18(1):115-129. PubMed ID: 26896317
[TBL] [Abstract][Full Text] [Related]
56. Encapsulation and controlled release of recombinant human erythropoietin from chitosan-carrageenan nanoparticles.
Bulmer C; Margaritis A; Xenocostas A
Curr Drug Deliv; 2012 Sep; 9(5):527-37. PubMed ID: 22812393
[TBL] [Abstract][Full Text] [Related]
57. Novel nanoparticles based on chitosan-dicarboxylate conjugates via tandem ionotropic/covalent crosslinking with tripolyphosphate and subsequent evaluation as drug delivery vehicles.
Dmour I; Taha MO
Int J Pharm; 2017 Aug; 529(1-2):15-31. PubMed ID: 28634140
[TBL] [Abstract][Full Text] [Related]
58. [Study on chitosan-modified tripterygium glycoside nanoparticles and its renal targeting property].
Chen XK; Wei YH; Yao JN; Zhao YM; Shang XG; Li FZ
Zhongguo Zhong Yao Za Zhi; 2013 Feb; 38(4):548-52. PubMed ID: 23713281
[TBL] [Abstract][Full Text] [Related]
59. Chitosan/carrageenan nanoparticles: effect of cross-linking with tripolyphosphate and charge ratios.
Rodrigues S; da Costa AM; Grenha A
Carbohydr Polym; 2012 Jun; 89(1):282-9. PubMed ID: 24750635
[TBL] [Abstract][Full Text] [Related]
60. Development and Optimization of Ciprofloxacin HCl-Loaded Chitosan Nanoparticles Using Box-Behnken Experimental Design.
Soliman NM; Shakeel F; Haq N; Alanazi FK; Alshehri S; Bayomi M; Alenazi ASM; Alsarra IA
Molecules; 2022 Jul; 27(14):. PubMed ID: 35889340
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
